Suppr超能文献

晚期 SARS-CoV-2 感染的肺部微生物谱:病例系列。

Pulmonary microbial spectrum in late-stage SARS-CoV-2 infection: a case series.

机构信息

School of Medicine, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), Taizhou University, 1139 Shifu Blvd, Jiaojiang District, Taizhou, Zhejiang, 318000, China.

出版信息

Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2037-2046. doi: 10.1007/s10096-024-04897-6. Epub 2024 Jul 20.

Abstract

Coronavirus disease 2019 (COVID-19), a kind of respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily spreads through the respiratory tract from human to human. Its extensive and rapid spread has led to a global pandemic, causing great harm to human health and economic development all over the world. Current known evidence indicates that SARS-CoV-2 has evolved accumulating multiple mutations, with altered infectivity and viral replication capacity. A better understanding of the complications of COVID-19 and its relationship with underlying diseases is crucial for the prevention and treatment of SARS-CoV-2. This case series reviewed case data of our 4 recent patients with severe or critical COVID-19, including treatment plan, status of pulmonary infection and their microbiology workup with metagenomic next-generation sequencing with bronchoalveolar lavage fluid. This report shed light on the significance of rapid and accurate clinical diagnosis and treatment on COVID-19.

摘要

新型冠状病毒肺炎(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的一种呼吸道疾病,主要通过呼吸道在人与人之间传播。其广泛而迅速的传播导致了全球大流行,对全世界的人类健康和经济发展造成了巨大危害。目前已知的证据表明,SARS-CoV-2 已经积累了多种突变,从而改变了其感染力和病毒复制能力。更好地了解 COVID-19 的并发症及其与潜在疾病的关系,对于 SARS-CoV-2 的预防和治疗至关重要。本病例系列回顾了我们最近 4 例重症或危重症 COVID-19 患者的病例数据,包括治疗方案、肺部感染状况及其微生物学检查,采用了支气管肺泡灌洗液的宏基因组下一代测序技术。本报告阐明了对 COVID-19 进行快速准确临床诊断和治疗的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验